FDA Approval
-
Biologics
Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use
Approval underscores Cerapedics’ commitment to investing in evidence that brings scientific rigor to bone grafting for spinal fusion. WESTMINSTER, Colo., Sept.…
Read More » -
Spine
DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease
Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials Achieves alignment with FDA on Chemistry,…
Read More » -
Regulatory
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global…
Read More » -
Neuro
Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on ReActiv8® Restorative Neurostimulation System™
U.S. patients implanted with ReActiv8 now eligible for full-body MRI scans DUBLIN, February 12, 2024–(BUSINESS WIRE)–Mainstay Medical Holdings plc today…
Read More » -
Recon
LimaCorporate Announces FDA Approval for new “PRIMA” Shoulder Platform Including Short Stem and TT Glenoid
Udine, Italy, Oct. 7, 2022 /PRNewswire/ — LimaCorporate proudly announces the FDA approval of a new shoulder platform focused on versatility and Operating…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
COVID-19
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health August 23, 2021 Today, the U.S. Food and Drug Administration approved the first…
Read More » -
Regulatory
NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement
Simplify® Cervical Artificial Disc achieved the highest overall clinical success rate at both one- and two-levels compared to any other…
Read More » -
Extremities
Nation’s Top Orthopedic Hospital Launches the First FDA Approved Digital Pathology Platform
NEW YORK, Feb. 9, 2021 /PRNewswire/ –Hospital for Special Surgery (HSS), the world’s leading academic medical center specializing in orthopedics, rheumatology, and related…
Read More » -
Regulatory
Simplify Medical Announces First Implantation of its Cervical Artificial Disc in the U.S. Following 1-Level Approval from the FDA
SUNNYVALE, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and…
Read More »